Home / BusinessBloombergBusinessBloomberg·Jul 8, 2026·1 min readIndia Fat-Loss Drug Sales Slow After Early Spike From GenericsGrowth in India’s obesity- and diabetes-drug market is losing steam just months after a surge triggered by the arrival of generic semaglutide products.View original source — Bloomberg ↗ShareCopy linkShare on XShare on FacebookRelated storiesSouth China Morning PostBusinessJul 8, 2026 · 1 minChina Molly Tea’s US$1.5 million Louis Vuitton fine sparks fierce debate, customer supportSouth China Morning PostCNABusinessJul 8, 2026 · 1 minCrypto firms prepare defenses as quantum threat to encryption draws nearerCNACNABusinessJul 8, 2026 · 1 minApple to spend $30 billion in Broadcom chips deal that will see Colorado factory expandCNAThe GuardianBusinessJul 8, 2026 · 1 minTrump’s policy mayhem is making even the Maga faithful consider walking awayThe Guardian
South China Morning PostBusinessJul 8, 2026 · 1 minChina Molly Tea’s US$1.5 million Louis Vuitton fine sparks fierce debate, customer supportSouth China Morning Post
CNABusinessJul 8, 2026 · 1 minCrypto firms prepare defenses as quantum threat to encryption draws nearerCNA
CNABusinessJul 8, 2026 · 1 minApple to spend $30 billion in Broadcom chips deal that will see Colorado factory expandCNA
The GuardianBusinessJul 8, 2026 · 1 minTrump’s policy mayhem is making even the Maga faithful consider walking awayThe Guardian